Tilray Backs First Human Study On Medical Marijuana Used For Breast Cancer Drug Side Effects

Tilray, Inc. (NASDAQ: TLRY) announced Thursday it has imported medical cannabis into the U.S. from Canada to back a new clinical trial.

Be the first to comment

Leave a Reply

Your email address will not be published.